The FDA issued 510(k) clearance for clinical use of the Accurian radiofrequency ablation platform (Medtronic) for the treatment of chronic pain.
Radiofrequency (RF) ablation of nerve tissues is a minimally invasive procedure in which current produced by radio waves heats up a small area of nerve tissue to stop it from sending pain signals, thereby reducing pain.
“The Accurian system combines proprietary hardware and quad core processing with advanced software for power and